CostacheVSMeekelJPCostacheA, et al. One-year single-center results of the Multilayer Flow Modulator stents for the treatment of type B aortic dissection. J Endovasc Ther. 2021;28(1):20–31.
2.
SultanSAcharyaYHynesN.The 4-D in management of complex aortic pathology. Ital J Vasc Endovasc Surg. 2020;27. In press.
3.
GarciaJBarkerAJMarklM.The role of imaging of flow patterns by 4D flow MRI in aortic stenosis. JACC Cardiovasc Imaging. 2019;12:252–266.
4.
HynesNSultanSElhelaliA, et al. Systematic review and patient-level meta-analysis of the Streamliner Multilayer Flow Modulator in the management of complex thoracoabdominal aortic pathology. J Endovasc Ther. 2016;23:501–512.
5.
SultanSHynesNKavanaghEP, et al. How does the Multilayer Flow Modulator work? The science behind the technical innovation. J Endovasc Ther. 2014;21:814–821.
6.
MorouçoPLattanziWAlvesN.Four-dimensional bioprinting as a new era for tissue engineering and regenerative medicine. Front Bioeng Biotechnol. 2017;5:61.
7.
SultanSKavanaghEPStefanovF, et al. Endovascular management of chronic symptomatic aortic dissection with the Streamliner Multilayer Flow Modulator: twelve-month outcomes from the global registry. J Vasc Surg. 2017;65:940–950.
8.
HynesNBerguerRParodiJC, et al. Management of complex complicated aortic dissection: natural history, translational research, simulation, bioconvergence, clinical evidence and literature review. Ital J Vasc Endovasc Surg. 2020;27. In press.
9.
SultanSBarrettNKamalMH, et al. Staged hybrid single lumen reconstruction (TIGER) in management of chronic symptomatic complex type B aortic dissection, techniques, and literature review. Ann Vasc Surg. 2020;65:261–270.
10.
SultanSBarrettNTawfickW, et al. Contemporary abdominal aortic aneurysm devices, three decades of research and development with big data. Why has the best graft not been produced yet? A missed opportunity. Ital J Vasc Endovasc Surg. 2019;26:121–134.
11.
SultanSKavanaghEPVeerasingamD, et al. Kinetic elephant trunk technique: early results in chronic symptomatic aortic dissection management. Ann Vasc Surg. 2019;57:244–252.
12.
van BakelTMJArthursCJNautaFJH, et al. Cardiac remodelling following thoracic endovascular aortic repair for descending aortic aneurysms. Eur J Cardiothorac Surg. 2019;55:1061–1070.
13.
SultanSConcannonJMcgarryJP, et al. Early results and lessons learned using the Streamliner Multilayer Flow Modulator in the management of complex thoracoabdominal aortic aneurysms and chronic symptomatic aortic dissection. Ital J Vasc Endovasc Surg. 2020;27. In press.
14.
SultanSHynesNSultanM; MFM Collaborators. When not to implant the multilayer flow modulator: lessons learned from application outside the indications for use in patients with thoracoabdominal pathologies. J Endovasc Ther. 2014; 21:96–112.
15.
VaislicCDFabianiJNChocronS, et al. Three-year outcomes with the Multilayer Flow Modulator for repair of thoracoabdominal aneurysms: a follow-up report from the STRATO trial. J Endovasc Ther. 2016;23:762–772.
16.
MorrisLStefanovFHynesN, et al. An experimental evaluation of device/arterial wall compliance mismatch for four stent-graft devices and a Multi-layer Flow Modulator device for the treatment of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2016;51:44–55.
17.
VaislicCDFabianiJNChocronS, et al. One-year outcomes following repair of thoracoabdominal aneurysms with the Multilayer Flow Modulator: report from the STRATO trial. J Endovasc Ther. 2014;21:85–95.
18.
RuffinoMARabbiaC; Italian Cardiatis Registry Investigators Group. Endovascular repair of peripheral and visceral aneurysms with the Cardiatis Multilayer Flow Modulator: one-year results from the Italian Multicenter Registry. J Endovasc Ther. 2012;19:599–610.
19.
OnitsukaSAkashiHTayamaK, et al. Long-term outcome and prognostic predictors of medically treated acute type B aortic dissections. Ann Thorac Surg. 2004;78:1268–1273.
20.
NautaFJTrimarchiSKammanAV, et al. Update in the management of type B aortic dissection. Vasc Med. 2016;21: 251–263.
21.
OsmanETanKTTseL, et al. The in-hospital costs of treating high-risk patients with fenestrated and branched endografts. J Vasc Surg. 2015;62:1457–1464.
22.
LoweCWorthingtonASerracino-InglottF, et al. Multilayer flow-modulating stents for thoraco-abdominal and perirenal aneurysms: the UK pilot study. Eur J Vasc Endovasc Surg. 2016;51:225–231.
23.
CalikEErkutB.Endovascular repair of a Stanford type A dissection with the Cardiatis multilayer flow modulator. Interact Cardiovasc Thorac Surg. 2019;28:321–323.
24.
SchafighMJKohistaniZSchillerW, et al. Retrograde Stanford type A dissection caused by a multilayer stent graft in a patient with chronic type B dissection. Interact Cardiovasc Thorac Surg. 2019;28:655–656.
25.
LópezPODauerLTLooseR, et al. ICRP Publication 139: Occupational Radiological Protection in Interventional Procedures [published correction appears in Ann ICRP. 2019 Sep;48(1):99]. Ann ICRP. 2018;47:1–118.
26.
DurhamCACambriaRPWangLJ, et al. The natural history of medically managed acute type B aortic dissection. J Vasc Surg. 2015;61:1192–1199.
27.
WangGJJacksonBMFoleyPJ, et al. National trends in admissions, repair, and mortality for thoracic aortic aneurysm and type B dissection in the National Inpatient Sample. J Vasc Surg. 2018;67:1649–1658.
28.
HosnMAGoffredoPZavalaJ, et al. Analysis of aortic growth rates in uncomplicated type B dissection. Ann Vasc Surg. 2018;48:133–140.
29.
MakaryMADanielM.Medical error-the third leading cause of death in the US. BMJ. 2016;353:i2139.
